Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells | Scientific Reports Nature
News
Q&A
Shopping
Auction
Rakuten
amazon